Insider · CIK 0001485939

ABERCROMBIE GEORGE B

Reports to the SEC for 6 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001485939

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+6,820 sh	—	—	36,431
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+49.9K sh	—	—	49,933
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+16.7K sh	—	—	29,611
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+39.1K sh	—	—	39,072
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+30K sh	—	—	30,022
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+12.9K sh	—	—	12,866
2022-04-18	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$3.32	+$16.6K	5,000
2022-04-18	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−5,000 sh	$11.04	−$55.2K	0
2022-04-18	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2022-02-15	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	5,000
2022-02-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−5,000 sh	$18.50	−$92.5K	0
2022-02-15	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$3.32	+$16.6K	5,000
2021-11-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−5,000 sh	$12.27	−$61.4K	0
2021-11-15	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$3.32	+$16.6K	5,000
2021-11-15	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	10,000
2021-09-15	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$2.63	+$13.2K	5,000
2021-09-15	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	0
2021-09-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−5,000 sh	$15.06	−$75.3K	0
2021-09-10	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2021-09-10	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+11K sh	$1.71	+$18.8K	14,000
2021-09-10	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$3.22	+$96.6K	44,000
2021-09-10	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$2.91	+$87.3K	74,000
2021-09-10	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−74K sh	$15.09	−$1.12M	0
2021-09-10	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantM Exercise/Conversion	Director	MExercise/Conversion	−11K sh	—	—	0
2021-09-10	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantM Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	0
2021-07-15	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$2.63	+$13.2K	8,000
2021-07-15	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	5,000
2021-07-15	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−5,000 sh	$15.69	−$78.5K	3,000
2021-05-25	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+40K sh	—	—	40,000
2021-05-24	BCRXBIOCRYST PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+6,667 sh	$2.63	+$17.5K	9,667
2021-05-24	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−6,667 sh	—	—	10,000
2021-05-24	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−6,667 sh	$13.90	−$92.7K	3,000
2021-05-10	BCRXBIOCRYST PHARMACEUTICALS INCS Sale	Director	SSale	−7,000 sh	$12.70	−$88.9K	3,000
2020-05-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+40K sh	—	—	40,000
2020-02-14	Fresh Tracks Therapeutics, Inc.Restricted Stock UnitsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+2,167 sh	$1.16	+$2,513.72	2,167
2020-02-14	Fresh Tracks Therapeutics, Inc.Stock OptionsA Award	Director, CHIEF EXECUTIVE OFFICER	AAward	+8,764 sh	$1.16	+$10.2K	8,764
2019-05-29	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+30K sh	—	—	30,000
2018-08-21	INVAInnoviva, Inc.S Sale	Sr. VP & Chief Comm. Officer	SSale	−8,000 sh	$14.11	−$113K	285,479
2018-08-20	INVAInnoviva, Inc.F Tax Payment	Sr. VP & Chief Comm. Officer	FTax Payment	−5,680 sh	$14.08	−$80K	293,479
2018-06-20	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+30K sh	—	—	30,000
2018-05-21	INVAInnoviva, Inc.S Sale	Sr. VP & Chief Comm. Officer	SSale	−8,000 sh	$14.40	−$115K	299,159
2018-05-20	INVAInnoviva, Inc.F Tax Payment	Sr. VP & Chief Comm. Officer	FTax Payment	−4,682 sh	$14.59	−$68.3K	305,235
2018-03-02	INVAInnoviva, Inc.A Award	Sr. VP & Chief Comm. Officer	AAward	+74.4K sh	—	—	309,917
2018-02-21	INVAInnoviva, Inc.S Sale	Sr. VP & Chief Comm. Officer	SSale	−8,000 sh	$16.51	−$132K	235,473
2018-02-20	INVAInnoviva, Inc.F Tax Payment	Sr. VP & Chief Comm. Officer	FTax Payment	−15.5K sh	$16.44	−$255K	243,473
2017-11-21	INVAInnoviva, Inc.S Sale	Sr. VP & Chief Comm. Officer	SSale	−5,215 sh	$13.26	−$69.1K	258,651
2017-11-20	INVAInnoviva, Inc.F Tax Payment	Sr. VP & Chief Comm. Officer	FTax Payment	−3,358 sh	$13.17	−$44.2K	263,866
2017-08-20	INVAInnoviva, Inc.F Tax Payment	Sr. VP & Chief Comm. Officer	FTax Payment	−2,886 sh	$12.28	−$35.4K	267,224
2017-05-24	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+30K sh	—	—	30,000
2017-05-20	INVAInnoviva, Inc.F Tax Payment	Sr. VP & Chief Comm. Officer	FTax Payment	−2,228 sh	$11.86	−$26.4K	270,110

Recent filings

Accepted (ET)
Jun 144
ABERCROMBIE GEORGE B0001127602-24-018705
SEC(opens sec.gov)
Jun 154
ABERCROMBIE GEORGE B0001127602-23-018765
SEC(opens sec.gov)
Jun 94
ABERCROMBIE GEORGE B0001127602-22-017153
SEC(opens sec.gov)
Apr 204
ABERCROMBIE GEORGE B0001127602-22-012272
SEC(opens sec.gov)
Feb 164
ABERCROMBIE GEORGE B0001127602-22-005295
SEC(opens sec.gov)
Nov 174
ABERCROMBIE GEORGE B0001127602-21-029440
SEC(opens sec.gov)
Sep 174
ABERCROMBIE GEORGE B0001127602-21-025496
SEC(opens sec.gov)
Sep 144
ABERCROMBIE GEORGE B0001127602-21-025252
SEC(opens sec.gov)

Companies

Address

C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200

DURHAM, NC, 27703